Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Cartesian Therapeutics (RNAC) Preferred Shares Issued (2023 - 2024)

Historic Preferred Shares Issued for Cartesian Therapeutics (RNAC) over the last 2 years, with Q1 2024 value amounting to $40.0 million.

  • Cartesian Therapeutics' Preferred Shares Issued changed N/A to $40.0 million in Q1 2024 from the same period last year, while for Dec 2024 it was $40.0 million, marking a year-over-year increase of 9753.09%. This contributed to the annual value of $40.0 million for FY2024, which is 9753.09% up from last year.
  • As of Q1 2024, Cartesian Therapeutics' Preferred Shares Issued stood at $40.0 million.
  • Over the past 5 years, Cartesian Therapeutics' Preferred Shares Issued peaked at $40.0 million during Q1 2024, and registered a low of $20.2 million during Q4 2023.